Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients

European Respiratory Journal

Volumn 47, Issue 6, 2016, Pages 1668-1679

  Morélot Panzini, Capucine ^a,b   Gilet, Hélène ^c   Aguilaniu, Bernard ^d   Devillier, Philippe ^e   Didier, Alain ^f   Perez, Thierry ^g   Pignier, Christophe ^h   Arnould, Benoit ^c   Similowski, Thomas ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Mapi Patient Centered Outcomes   (France)

^d UNIV GRENOBLE ALPES   (France)

^e FOCH HOSPITAL   (France)

^f SERVICE DE PNEUMOLOGIE   (France)

^g UNIV LILLE   (France)

^h INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFFECT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PRACTICE; CONTROLLED STUDY; DEPRESSION; DYSPNEA; EMOTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDIMENSIONAL DYSPNEA PROFILE; OBSERVATIONAL STUDY; OUTPATIENT; PATIENT CODING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE ASSESSMENT; SENSORY SYSTEM; CLINICAL TRIAL; CLUSTER ANALYSIS; COMPLICATION; FORCED EXPIRATORY VOLUME; FRANCE; LUNG; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHENOTYPE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SMOKING; TIME FACTOR;

AGED; CLUSTER ANALYSIS; DEPRESSION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FRANCE; HUMANS; LUNG; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENTS; PHENOTYPE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SMOKING; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 84973474066     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01998-2015     Document Type: Article

References (34)

1. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440.
2. Hajiro T, Nishimura K, Tsukino M, et al. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999; 116: 1632-1637.
3. Tsiligianni I, Kocks J, Tzanakis N, et al. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J 2011; 20: 257-268.
4. Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 2009; 167: 53-60.
5. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185: 435-452.
6. Laviolette L, Laveneziana P. Dyspnoea: a multidimensional and multidisciplinary approach. Eur Respir J 2014; 43: 1750-1762.
7. Currow DC, Johnson MJ. Distilling the essence of breathlessness: the first vital symptom. Eur Respir J 2015; 45: 1526-1528.
8. Yorke J, Russell AM, Swigris J, et al. Assessment of dyspnea in asthma: validation of the Dyspnea-12. J Asthma 2011; 48: 602-608.
9. Tanaka K, Akechi T, Okuyama T, et al. Development and validation of the Cancer Dyspnoea Scale: a multidimensional, brief, self-rating scale. Br J Cancer 2000; 82: 800-805.
10. Banzett RB, Pedersen SH, Schwartzstein RM, et al. The affective dimension of laboratory dyspnea: air hunger is more unpleasant than work/effort. Am J Respir Crit Care Med 2008; 177: 1384-1390.
11. Meek PM, Banzett R, Parshall MB, et al. Reliability and validity of the multidimensional dyspnea profile. Chest 2012; 141: 1546-1553.
12. O'Donnell CR, Schwartzstein RM, Lansing RW, et al. Dyspnea affective response: comparing COPD patients with healthy volunteers and laboratory model with activities of daily living. BMC Pulm Med 2013; 13: 27.
13. Parshall MB, Meek PM, Sklar D, et al. Test-retest reliability of multidimensional dyspnea profile recall ratings in the emergency department: a prospective, longitudinal study. BMC Emerg Med 2012; 12: 6.
14. Banzett RB, O'Donnell CR, Guilfoyle TE, et al. Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research. Eur Respir J 2015; 45: 1681-1691.
15. Banzett RB, Adams L, O'Donnell CR, et al. Using laboratory models to test treatment: morphine reduces dyspnea and hypercapnic ventilatory response. Am J Respir Crit Care Med 2011; 184: 920-927.
16. Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008; 134: Suppl. 4, 43S-56S.
17. Bailey PH The dyspnea-anxiety-dyspnea cycle - COPD patients' stories of breathlessness: "It's scary /when you can't breathe". Qual Health Res 2004; 14: 760-778.
18. Chavannes NH, Huibers MJ, Schermer TR, et al. Associations of depressive symptoms with gender, body mass index and dyspnea in primary care COPD patients. Fam Pract 2005; 22: 604-607.
19. Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 2002; 32: 959-976.
20. Aguilaniu B, Gonzalez-Bermejo J, Regnault A, et al. Disability related to COPD tool (DIRECT): towards an assessment of COPD-related disability in routine practice. Int J Chron Obstruct Pulmon Dis 2011; 6: 387-398.
21. Williams EJ The comparison of regression variables. J R Stat Soc Series B Stat Methodol 1959; 21: 396-399.
22. Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374: 704-711.
23. Carrieri-Kohlman V, Donesky-Cuenco D, Park SK, et al. Additional evidence for the affective dimension of dyspnea in patients with COPD. Res Nurs Health 2010; 33: 4-19.
24. Carrieri-Kohlman V, Gormley JM, Douglas MK, et al. Differentiation between dyspnea and its affective components. West J Nurs Res 1996; 18: 626-642.
25. Carrieri-Kohlman V, Gormley JM, Eiser S, et al. Dyspnea and the affective response during exercise training in obstructive pulmonary disease. Nurs Res 2001; 50: 136-146.
26. Smith J, Albert P, Bertella E, et al. Qualitative aspects of breathlessness in health and disease. Thorax 2009; 64: 713-718.
27. von Leupoldt A, Taube K, Henkhus M, et al. The impact of affective states on the perception of dyspnea in patients with chronic obstructive pulmonary disease. Biol Psychol 2010; 84: 129-134.
28. Wadell K, Webb KA, Preston ME, et al. Impact of pulmonary rehabilitation on the major dimensions of dyspnea in COPD. COPD 2013; 10: 425-435.
29. Janssens T, De Peuter S, Stans L, et al. Dyspnea perception in COPD: association between anxiety, dyspnea-related fear, and dyspnea in a pulmonary rehabilitation program. Chest 2011; 140: 618-625.
30. Perez T, Burgel PR, Paillasseur JL, et al. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015; 10: 1663-1672.
31. Williams M, Cafarella P, Olds T, et al. Affective descriptors of the sensation of breathlessness are more highly associated with severity of impairment than physical descriptors in people with COPD. Chest 2010; 138: 315-322.
32. von Leupoldt A, Taube K, Schubert-Heukeshoven S, et al. Distractive auditory stimuli reduce the unpleasantness of dyspnea during exercise in patients with COPD. Chest 2007; 132: 1506-1512.
33. Norweg A, Collins EG. Evidence for cognitive-behavioral strategies improving dyspnea and related distress in COPD. Int J Chron Obstruct Pulmon Dis 2013; 8: 439-451.
34. Donesky D, Nguyen HQ, Paul SM, et al. The affective dimension of dyspnea improves in a dyspnea self-management program with exercise training. J Pain Symptom Manage 2014; 47: 757-771.